Document is current
Any future updates will be listed below
-
Authors
Kiedrowska, Marlena https://orcid.org/0000-0003-2318-3375
Foryś, Weronika Jasmina https://orcid.org/0000-0002-2704-6186
Gołębiewska, Agnieszka https://orcid.org/0000-0002-9662-8243
Waśko, Izabela https://orcid.org/0000-0001-5494-3635
Ronkiewicz, Patrycja https://orcid.org/0000-0003-4427-5076
Kuch, Alicja https://orcid.org/0000-0001-5416-1422
Wróbel-Pawelczyk, Izabela https://orcid.org/0000-0002-4726-5984
Wroczyński, Michał
Hryniewicz, Waleria https://orcid.org/0000-0002-3651-9790
Skoczyńska, Anna https://orcid.org/0000-0002-2247-830X
-
Funding
Funding for this research was provided by:
GlaxoSmithKline
Ministerstwo Nauki i Szkolnictwa Wyższego
- License Information
-
More Information
Article History
Received: 3 February 2022
Accepted: 10 May 2022
First Online: 18 May 2022
Declarations
:
: The study was conducted as continuous surveillance in accordance with the World Health Medical Association 1966 Declaration of Helsinki and the EU rules of Good Clinical Practice.
: Not applicable.
: The authors declare no competing interests.
